2026-01-27 - Analysis Report
**Company Overview**
Eli Lilly and Company is a global healthcare leader that discovers, develops, and delivers innovative solutions to address some of the world's most pressing health-care needs.

**Key Stats**

* Cumulative return of review stock: **660.89%**
* Cumulative return of comparison stock (S&P 500, VOO): **127.58%**
* Divergence (max: 577.90, min: -22.40, current: 535.60, relative divergence: **93.00%**)

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.